Collective X Health Raises $3.2 Million in Pre-Seed Funding
Collective X Health, a San Francisco-based company that delivers evidence-backed, female-specific insights across the smart health ecosystem, has announced a successful pre-seed funding round, securing $3.2 million. The round was co-led by Council Capital and Anthemis Female Innovators Lab Fund. Other notable investors include SoGal Ventures, Emerson Collective, Muse Capital, and Segal Ventures.
Company Background
Collective X Health is focused on providing tailored health insights specifically for women, leveraging data and technology to enhance the smart health ecosystem. This approach aims to fill a gap in the market for health solutions that are truly designed with women's needs in mind.
Leadership
Angelica Marden, a co-founder and the Chief Brand Officer of Collective X Health, plays a key role in steering the company's brand and market strategy. Her leadership is crucial as the company moves forward with its growth plans.
Use of Funds
While specific plans for the use of the newly acquired funds were not detailed, pre-seed funding typically supports key areas such as product development, team expansion, and market entry strategies. Given Collective X Health's focus, it is likely that the funds will be directed toward enhancing their data-driven health insights platform.
Investor Insights
The involvement of Council Capital and Anthemis Female Innovators Lab Fund as lead investors highlights a growing interest in health tech solutions that cater specifically to women. This funding round reflects a broader trend of investment in companies that address underrepresented areas in healthcare.
Collective X Health's recent funding round marks a significant step in their journey to revolutionize women's health through technology and data insights. With strong backing from industry investors, the company is well-positioned to expand its influence in the smart health sector.